Oregon updates cannabis health guidance for the first time since 2017

The Oregon Health Authority released a 20-page evidence review recognizing potential benefits for chronic pain, certain seizure disorders, multiple sclerosis spasticity and chemotherapy-related nausea while also detailing risks. Oklahoma retailers and manufacturers can use the framework to align staff education and product communications with evidence without making unsupported medical claims.